1. Web alert

   News Pages: 193 - 194

2. Literature alert

   Abstract Pages: 195 - 197

3. Risk factors for diabetic neuropathy and foot ulceration

   • Amanda Adler

   OriginalPaper Pages: 202 - 207

4. Measurement of somatic neuropathy for clinical practice and clinical trials

   • Vern A. La Scott
   • Solomon Tesfaye

   OriginalPaper Pages: 208 - 215

5. Diagnosis and treatment of diabetic autonomic neuropathy

   • Dan Ziegler

   OriginalPaper Pages: 216 - 227

6. Update on charcot neuroarthropathy

   • Edward B. Jude
   • Andrew J. M. Boulton

   OriginalPaper Pages: 228 - 232

7. Classification of wounds of the diabetic foot

   • David G. Armstrong
   • Edgar J. G. Peters

   OriginalPaper Pages: 233 - 238

8. Potential gene transfer treatment for ischemic neuropathy

   • Andrew J. M. Boulton

   Clinical Trials Report Pages: 239 - 239

9. The meaning of microalbuminuria in type 1 diabetes: The need for a new paradigm

   • Sharon G. Adler
   • Cynthia C. Nast

   Clinical Trials Report Pages: 241 - 244

10. Risk predictors in patients with diabetic nephropathy

    • Paola Fioretto
    • Maria Luiza Caramori
    • Michael Mauer

    OriginalPaper Pages: 245 - 250

11. Treatment of hypertension in diabetic patients with nephropathy

    • Radko Komers
    • Sharon Anderson

    OriginalPaper Pages: 251 - 260

12. C-peptide: A new potential in the treatment of diabetic nephropathy

    • John Wahren
    • Karin Ekberg
    • Bo-Lennart Johansson

    OriginalPaper Pages: 261 - 266

13. Angiotensin receptor blockers in diabetic nephropathy

    • Deborah A. Price
    • Norman K. Hollenberg

    OriginalPaper Pages: 267 - 274

14. Genetics of diabetic nephropathy in the pima indians

    • Giuseppina Imperatore
    • William C. Knowler
    • Robert L. Hanson

    OriginalPaper Pages: 275 - 281

15. Oxidative stress in diabetic nephropathy: Basic and clinical information

    • Hunjoo Ha
    • Hi Bahl Lee

    OriginalPaper Pages: 282 - 287